John Kendrick, MD
Vascular Surgery · Columbia, TNNPI 1265621635
Payments from drug & device makers
What this record shows
39 manufacturers reported payments, led by Medtronic at 41.9% of the total. Reporting peaked in 2019 at $7,333 and has fallen 93.1% since, to $508 in 2025.
Across 279 payments — averaging $55.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- Cardiovascular Systems Inc.$3K
- Bard Peripheral Vascular, Inc.$2K
- Philips North America LLC$732
- Silk Road Medical, Inc.$469
- Penumbra, Inc.$377
- plus $3K from 33 others
What the payments were for
- Travel & lodging$8,76356%
- Food & beverage$6,83544%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 15 | $6,531 |
| Cardiovascular Systems Inc. | 61 | $2,756 |
| Bard Peripheral Vascular, Inc. | 53 | $2,008 |
| Philips North America LLC | 2 | $732 |
| Silk Road Medical, Inc. | 11 | $469 |
| Penumbra, Inc. | 20 | $377 |
| Boston Scientific | 12 | $273 |
| Abbott | 17 | $263 |
| Cordis US CORP. | 13 | $235 |
| BD | 10 | $217 |
| Endologix LLC | 1 | $180 |
| Terumo Medical Corporation | 3 | $152 |
| Stryker | 3 | $149 |
| Reflow Medical Inc | 8 | $143 |
| W. L. Gore & Associates, Inc. | 7 | $138 |
| Laminate Medical Technologies Inc. | 1 | $121 |
| Inari Medical, Inc. | 2 | $103 |
| Smith+Nephew | 5 | $89 |
| Cardinal Health 200 LLC | 4 | $73 |
| Innovation Technologies Inc | 2 | $64 |
| Lemaitre Vascular, Inc. | 4 | $58 |
| Surmodics, Inc. | 3 | $57 |
| Johnson & Johnson(2 entities) | 3 | $53 |
| Angiodynamics, Inc. | 2 | $45 |
| Venclose Inc. | 2 | $39 |
| Solventum Corporation | 2 | $37 |
| Alpha Orthopedic Systems | 1 | $26 |
| Covidien LP | 1 | $26 |
| Cagent Vascular Inc | 1 | $23 |
| Shockwave Medical, Inc | 1 | $23 |
| Organogenesis Inc. | 1 | $22 |
| Neuros Medical, Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Bolton Medical Inc | 1 | $16 |
| Pfizer | 1 | $14 |
| Teleflex LLC | 1 | $13 |
| Bolder Surgical LLC | 1 | $12 |
| Merit Medical Systems Inc | 1 | $12 |
| Biocompatibles, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IN.PACT Admiral$6,077
- Diamondback Peripheral$1,357
- IGT D Peripheral$732
- Peripheral Orbital Atherectomy System$449
- ENROUTE Transcarotid Neuroprotection System$214
- ENROUTE Transcarotid Stent System$214
- ENHANCE Transcarotid Peripheral Access Kit$214
- ENROUTE 0.014 Guidewire$214
- Ovation$180
- ALTO$180
- Azur CX Detachable$123
- ANGIO-SEAL$123
- VasQ External Device$121
- COVERA$115
- VENOVO$112
- Endurant$112
How this compares
$15,598 in reported general payments places this provider in the 75th percentile of 117 vascular surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 82 | $76,386 |
| XareltoRivaroxaban | 36 | $28,528 |
| ClopidogrelClopidogrel Bisulfate | 308 | $3,422 |
| Atorvastatin Calcium | 16 | $335 |
| Cilostazol | 15 | $310 |
| Pravastatin Sodium | 27 | $208 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 53 | $130 |
| Pantoprazole Sodium | 15 | $79 |
| Prednisone | 14 | $13 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $14 | $76,38682 claims |
| Johnson & JohnsonXarelto | $53 | $28,52836 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 117 vascular surgery providers in Tennessee.
Other vascular surgery in Columbia
- Patrick YuColumbia$9K
- Daniel ClairNashville$993K
- Anton Dias PereraGermantown$832K
- Bryan FisherHendersonville$417K
- Christopher LesarChattanooga$311K
- Billy KimMount Juliet$140K
- William HarrisChattanooga$122K
- Mark FugateChattanooga$100K
- Heesuk YoonJohnson City$95K
- Scott StevensKnoxville$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.